DoR, PFS, and OS among patients with R/R FL. Kaplan-Meier curves describing the investigator-assessed DoR (A) and PFS (B) per Lugano 2014 criteria, and OS (C) of all patients with R/R FL enrolled in the BRUIN study. Patients who were alive and without documented progressive disease (DoR, PFS) as of the data analysis cutoff date were censored. Patients who were alive or lost to follow-up (OS) as of the data analysis cutoff date were censored. Data cutoff of 27 January 2025. NE, not estimable.